Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven Neurodegeneration
线粒体 CYP2E1 在化学品暴露驱动的神经变性中的作用
基本信息
- 批准号:9319548
- 负责人:
- 金额:$ 5.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeBiological AssayBullaCYP2E1 geneCaenorhabditis elegansCell DeathCellsCessation of lifeChemical ExposureClinicalDevelopmentDisease ProgressionEarly DiagnosisEndoplasmic ReticulumEnvironmentEnvironmental PollutantsEnvironmental Risk FactorExposure toFellowshipFluorescence MicroscopyFunctional disorderGeneticGenetic RiskGenus HippocampusGoalsHealthHepatocyteHumanIn SituInterventionKnowledgeLeadLinkLiverLongevityMeasurementMeasuresMembrane PotentialsMetabolicMetabolic ActivationMetabolismMethanolMitochondriaMitochondrial DNAMitochondrial ProteinsModelingMutationNematodaNerve DegenerationNeurodegenerative DisordersNeuronsOrganellesPC12 CellsParkinson DiseasePathogenesisPersonsPesticidesPharmaceutical PreparationsPlayPopulationPreventive measureResearchRespirationRisk AssessmentRisk FactorsRoleSolventsSubstantia nigra structureSymptomsTestingToxic Environmental SubstancesToxic effectToxicant exposureTransgenic OrganismsTrichloroethyleneUnited States National Institutes of HealthWhole Organismbasecell injurydopaminergic neuronexperimental studyimprovedin vivoinstrumentmitochondrial dysfunctionmitochondrial membranenervous system disorderneuron lossneuroprotectionparkin gene/proteinprophylacticrespiratory proteinsmall moleculetargeted treatmenttherapeutic targettoxicant
项目摘要
Project Summary/Abstract
Parkinson's Disease (PD) is one of the most common neurodegenerative disorders, affecting >1% of the
population over age 60. PD pathophysiology includes preferential loss of dopaminergic neurons in the
substantia nigra (SN), and has been linked to both genetic and environmental risk factors. However, genetics
can only explain 5-10% of late-onset cases, so environment may play a larger role in most cases. PD has been
demonstrated at the cellular level to involve mitochondrial dysfunction. Multiple environmental toxicants known
to be toxic to mitochondria require metabolic activation to exert this toxicity through reactive metabolites that
damage vulnerable mitochondrial proteins and DNA. Two well-known examples of metabolically activated
compounds are trichloroethylene, a pervasive environmental pollutant, and methanol, a common solvent and
fuel additive; both trichloroethylene and methanol are activated by cytochrome P450 2E1 (CYP2E1). CYP2E1
has traditionally been studied in the endoplasmic reticulum (ER) of liver hepatocytes; however, it is also
expressed in SN dopaminergic neurons. Moreover, CYP2E1 is bimodally targeted to ER and mitochondria in
those cells. Relatively little is known about the consequence of mitochondrial CYP2E1 localization on
mitochondrial integrity and/or function and ultimately pathogenesis of neurodegenerative diseases.
This NIH postdoctoral fellowship proposal will assess the role of mitochondrial CYP2E1 (mtCYP2E1) in
mitochondrial dysfunction and neurodegeneration due to the activation of trichloroethylene and methanol in
transgenic human CYP2E1-expressing PC-12 cells and C. elegans (in vivo). We hypothesize that activation
of these toxicants by CYP2E1 within mitochondrial organelles will cause localized damage that triggers
mitochondrial dysfunction and drives neurodegeneration. To test this hypothesis, mitochondrial
dysfunction will be assessed in cells and in vivo through a battery of mitochondrial assays including whole-cell
and whole-organism respiration assays using a Seahorse XF instrument, ATP measurements, and
assessment of mitochondrial membrane potential. Neurodegeneration induced by methanol and
trichloroethylene will be assessed in vivo by fluorescence microscopy of live C. elegans nematodes bearing
GFP-tagged neurons. Overall, knowledge gained from this study will aid in development of more accurate risk
assessments for neurodegeneration triggered by exposures to environmental toxicants and could provide new
targets for intervention and/or neuroprotection. The following aims will be pursued:
Specific Aim 1: Determine CYP2E1-dependent mitochondrial dysfunction induced by toxicants.
Specific Aim 2: Assess the role of mitochondrial CYP2E1 in toxicant-induced neurodegeneration.
项目概要/摘要
帕金森病 (PD) 是最常见的神经退行性疾病之一,影响超过 1% 的人
60 岁以上人群。PD 病理生理学包括多巴胺能神经元优先丧失
黑质(SN),与遗传和环境风险因素有关。然而,遗传学
只能解释 5-10% 的迟发病例,因此环境在大多数情况下可能发挥更大的作用。 PD 已
在细胞水平上被证明涉及线粒体功能障碍。已知多种环境毒物
对线粒体有毒需要代谢激活才能通过反应性代谢物发挥这种毒性
损害脆弱的线粒体蛋白质和 DNA。代谢激活的两个著名例子
化合物是三氯乙烯(一种普遍存在的环境污染物)和甲醇(一种常见溶剂)
燃油添加剂;三氯乙烯和甲醇均被细胞色素 P450 2E1 (CYP2E1) 激活。 CYP2E1
传统上是在肝细胞的内质网(ER)中进行研究;然而,这也是
在 SN 多巴胺能神经元中表达。此外,CYP2E1 双峰靶向 ER 和线粒体
那些细胞。关于线粒体 CYP2E1 定位对线粒体的影响知之甚少。
线粒体完整性和/或功能以及神经退行性疾病的最终发病机制。
该 NIH 博士后奖学金提案将评估线粒体 CYP2E1 (mtCYP2E1) 在
由于三氯乙烯和甲醇的活化导致线粒体功能障碍和神经变性
转基因人表达 CYP2E1 的 PC-12 细胞和秀丽隐杆线虫(体内)。我们假设激活
线粒体细胞器内的 CYP2E1 释放这些毒物会造成局部损伤,从而引发
线粒体功能障碍并导致神经退行性变。为了验证这一假设,线粒体
将通过一系列线粒体检测(包括全细胞检测)在细胞和体内评估功能障碍
使用 Seahorse XF 仪器进行整个生物体呼吸测定、ATP 测量和
线粒体膜电位的评估。甲醇诱导的神经变性
三氯乙烯将通过活体线虫的荧光显微镜进行体内评估
GFP 标记的神经元。总体而言,从本研究中获得的知识将有助于开发更准确的风险
对暴露于环境毒物引发的神经退行性疾病进行评估,可以提供新的
干预和/或神经保护的目标。我们将追求以下目标:
具体目标 1:确定毒物诱导的 CYP2E1 依赖性线粒体功能障碍。
具体目标 2:评估线粒体 CYP2E1 在毒物诱导的神经变性中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Helene Hartman其他文献
Jessica Helene Hartman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica Helene Hartman', 18)}}的其他基金
Subcellular-targeted CYP2E1 and alcohol in the brain
大脑中亚细胞靶向 CYP2E1 和酒精
- 批准号:
10496067 - 财政年份:2023
- 资助金额:
$ 5.67万 - 项目类别:
Regulation and Consequences of Cytochrome P450 2E1
细胞色素 P450 2E1 的调节和后果
- 批准号:
10713697 - 财政年份:2023
- 资助金额:
$ 5.67万 - 项目类别:
Exercise, MANF, and Chemical-Induced Neurodegeneration
运动、MANF 和化学物质引起的神经变性
- 批准号:
10380263 - 财政年份:2021
- 资助金额:
$ 5.67万 - 项目类别:
Exercise, MANF, and Chemical-Induced Neurodegeneration
运动、MANF 和化学物质引起的神经变性
- 批准号:
10307629 - 财政年份:2020
- 资助金额:
$ 5.67万 - 项目类别:
Exercise, MANF, and Chemical-Induced Neurodegeneration
运动、MANF 和化学物质引起的神经变性
- 批准号:
10513154 - 财政年份:2020
- 资助金额:
$ 5.67万 - 项目类别:
Exercise, MANF, and Chemical-Induced Neurodegeneration
运动、MANF 和化学物质引起的神经变性
- 批准号:
10513823 - 财政年份:2020
- 资助金额:
$ 5.67万 - 项目类别:
Exercise, MANF, and Chemical-Induced Neurodegeneration
运动、MANF 和化学物质引起的神经变性
- 批准号:
10217454 - 财政年份:2020
- 资助金额:
$ 5.67万 - 项目类别:
Exercise, MANF, and chemical-induced neurodegeneration
运动、MANF 和化学物质引起的神经变性
- 批准号:
10020404 - 财政年份:2019
- 资助金额:
$ 5.67万 - 项目类别:
Role of Mitochondrial CYP2E1 in Chemical Exposure-Driven Neurodegeneration
线粒体 CYP2E1 在化学品暴露驱动的神经变性中的作用
- 批准号:
9189444 - 财政年份:2016
- 资助金额:
$ 5.67万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
- 批准号:82301214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
- 批准号:
10590033 - 财政年份:2024
- 资助金额:
$ 5.67万 - 项目类别:
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 5.67万 - 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 5.67万 - 项目类别:
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
GPR39 作为衰老相关血管认知障碍和痴呆的治疗靶点
- 批准号:
10734713 - 财政年份:2023
- 资助金额:
$ 5.67万 - 项目类别:
Asian American Prevention Research: A Populomics Epidemiology Cohort (ARISE)
亚裔美国人预防研究:人口组学流行病学队列 (ARISE)
- 批准号:
10724884 - 财政年份:2023
- 资助金额:
$ 5.67万 - 项目类别: